Form 4: Century Therapeutics SVP Sells Shares for Tax Obligations
Insider Transaction Report
Century Therapeutics' SVP of Finance & Operations, Douglas Carr, sold 7,043 shares of common stock to cover tax withholding obligations.
Summary
- Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), sold 7,043 shares of common stock.
- The transaction occurred on March 12, 2026, at a price of $2.549 per share.
- The sale was automatic and not at the discretion of Mr. Carr, specifically to cover tax withholding obligations related to the vesting of restricted stock units.
- Following this transaction, Mr. Carr beneficially owns 507,261 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was explicitly for tax withholding purposes and not a discretionary divestment, which is a common and expected occurrence for executive compensation.
Management Comments
- The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- Such sales were automatic and not at the discretion of the Reporting Person.
Industry Context
StockSavvy.ai notes that sales by insiders to cover tax obligations upon the vesting of restricted stock units are a common and routine occurrence in the biotechnology industry, reflecting standard compensation practices rather than a change in sentiment towards the company.
Stakeholder Impact
- Shareholders: Minimal direct impact as it's a routine, non-discretionary sale for tax purposes, not indicative of a change in insider confidence.
Key Dates
| Date | Description |
|---|---|
| 03/12/2026 | Transaction Date for the sale of common stock |
| 03/16/2026 | Signature Date of the Form 4 filing |
Recommendation
holdThe transaction is a routine, non-discretionary sale by an officer to cover tax obligations associated with restricted stock unit vesting. It does not reflect a change in the officer's investment sentiment or the company's fundamentals, thus warranting a 'hold' recommendation based solely on this filing.
Keywords
Century Therapeutics, IPSC, Douglas Carr, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Officer Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.